This is consistent with the observation that overexpression of constitutively active AKT2 not only failed to rescue Gli1 activity in pancreatic cancer cells lacking K-Ras, but also further decreased it, albeit not significantly [7]. The gene discussed is KRAS; the disease is familial pancreatic carcinoma.